The omega-3 market is projected to experience a robust compound annual growth rate (CAGR) of 12.2%, increasing from USD 4,362.2 million in 2025 to USD 7,756.4 million by 2030. Rising awareness among consumers about cardiovascular health, brain function, eye health, and overall wellness, coupled with the growing demand for natural and functional ingredients, is expected to drive demand for omega-3 in the coming years. Omega-3 ingredients are gaining significant traction due to their clinically proven health benefits and wide range of applications. As the food and beverage, nutraceutical, and dietary supplement industries continue to expand, omega-3 products in concentrated and innovative forms are witnessing increasing adoption. Moreover, the use of omega-3 is expanding in pharmaceuticals, infant nutrition, and animal feed, further driving market development and creating new opportunities globally.
To know about the assumptions considered for the study download the pdf brochure
Collaborations between food tech companies, pharmaceutical players, aquaculture firms, and biotech researchers are accelerating advancements in omega-3 extraction, purification, and formulation. These partnerships are enabling the development of sustainable sources such as algae-based omega-3, alongside traditional fish oil and krill oil, broadening their accessibility across various consumer bases. Functional foods and beverages, dietary supplements, fortified dairy, and skincare products are increasingly incorporating omega-3, positioning it as a versatile and reliable ingredient. With a growing shift toward preventive healthcare and sustainable nutrition, the demand for omega-3 is expected to increase significantly, supported by its proven efficacy and the rising demand for clean-label, science-backed products.
Market growth is driven by several factors, including rising consumer awareness of cardiovascular health, brain development, and overall wellness, increasing prevalence of lifestyle-related disorders such as obesity, diabetes, and heart disease, and the growing demand for functional foods and dietary supplements. The role of omega-3 in supporting heart, eye, cognitive, and joint health is well-established, and omega-3 ingredients are increasingly being incorporated into food and beverages, supplements, pharmaceuticals, and personal care products. Owing to their strong global presence, some of the major players in the omega-3 market include BASF SE (Germany), Cargill, Incorporated (US), dsm-firmenich (Netherlands), ADM (US), Kerry Group plc (Ireland), Aker BioMarine (Norway), Croda International PLC (UK), Corbion (Netherlands), Pelagia AS (Norway), KD Pharma Group SA (Switzerland), GC Rieber (Norway), Cooke Aquaculture Inc. (Canada), GOLDEN OMEGA (Chile), Polaris (France), Btsa (Spain), KinOmega Biopharm Inc (China), Rimfrost AS (Norway), Mara Renewables (Canada), Cellana Inc. (US), AlgaeCytes Limited (UK), and others. These companies employ a combination of organic and inorganic growth strategies, including partnerships, acquisitions, product launches, facility expansions, and collaborations, to strengthen their market position and meet the growing demand worldwide.
Scientific research, clinical trials, and advanced extraction and purification technologies, particularly in sustainable sources like algae-derived omega-3, are being increasingly utilized by leading players to enhance product efficacy, stability, and bioavailability. This is creating a strong growth platform for omega-3 across functional food, dietary supplements, pharmaceuticals, pet nutrition, and personal care industries.
BASF is one of the world’s largest chemical companies, operating in 93 countries with 234 production sites worldwide. Founded in 1865, BASF pioneered the Verbund concept, which remains central to its operations. The Verbund system creates efficient value chains by linking production, utilizing by-products as feedstock, and optimizing resources, energy, and emissions. In 2024, the BASF Group was organized into six segments: Chemicals, Materials, Industrial Solutions, Surface Technologies, Nutrition & Care, and Agricultural Solutions. The company operates in over 90 countries across North America, Europe, South America, Asia Pacific, Africa, and the Middle East. It has over 100 production and research & development sites across North America, as well as six Verbund sites spanning Europe, North America, and Asia. All the production plants, energy and material flows, logistics, and site infrastructures are integrated at Verbund sites.
The Nutrition & Care segment includes the Care Chemicals and Nutrition & Health divisions, focusing on ingredients for consumer products in nutrition, home care, and personal care. Its customer base spans the food, animal feed, pharmaceutical, cosmetics, and cleaning industries. In 2024, Nutrition & Care contributed 16.6% to BASF’s total sales, with R&D expenses of USD 86.58 million and investments, including acquisitions, amounting to USD 3.68 million. This segment plays a crucial role in delivering innovative, sustainable solutions in personal care and health-related markets, including Omega-3 ingredients. With over 180 years of expertise in omega-3 innovation, BASF SE is a leading player in the omega-3 market. The company operates manufacturing sites in Sandefjord, Norway, Callanish, Scotland, and others. BASF SE is dedicated to producing high-quality omega-3 solutions tailored to the active pharmaceutical ingredient (API) and nutritional supplement markets.
dsm-firmenich (DSM) is one of the leading companies in science-based solutions for health and nutrition. With a focus on innovation and sustainability, DSM provides a diverse range of products across multiple industries, including food, pharmaceuticals, animal nutrition, and personal care. In May 2023, DSM (Netherlands) and Switzerland-based Firmenich International SA merged to establish dsm-firmenich (Switzerland/Netherlands). This merger aimed to establish dsm-firmenich as the foremost partner for creation and innovation in nutrition, beauty, and well-being. With a combined revenue of approximately USD 13.17 billion, the new entity now operates across four segments: Taste, Texture & Health; Health, Nutrition & Care; Animal Nutrition & Health; and Corporate Activities.
Within the Health, Nutrition & Care (HNC) segment, the company focuses on improving health outcomes by delivering essential nutrients across key areas such as Early Life Nutrition, Dietary Supplements, Pharmaceuticals, Medical Nutrition, and Biomedical Materials. dsm-firmenich provides a variety of omega-3 ingredients suitable for a wide range of uses, spanning from dietary supplements, infant nutrition, and fortified foods to animal nutrition. These ingredients encompass omega-3s derived from fish oil and alternative sources such as algal oil. This segment plays a critical role in advancing nutrition science and medical innovation to support immunity, recovery, and overall quality of life. It has a significant geographical presence across all the major regions, namely, North America, Europe, Latin America, Asia Pacific, and Africa, with over 200 sites and offices present in nearly 50 countries. In October 2023, dsm-firmenich (Netherlands) launched life’sOMEGA O3020 in North America, a premier single-source algal omega-3 supplement designed with an EPA/DHA ratio that closely mirrors the composition naturally found in fish oil, providing a sustainable and effective alternative to traditional sources.
Kerry Group plc is an Irish-headquartered global leader in taste and nutrition, providing innovative ingredient solutions for food, beverage, and pharmaceutical applications, all with an eye toward enhancing health and wellness through science-based, clean-label ingredients. Kerry has a geographical presence in over 140 countries across North America, Europe, South America, Asia Pacific, the Middle East, and Africa. It operates over 147 manufacturing sites in 32 countries across all six continents. Some of its major subsidiaries include Oakhouse Foods (UK), Island Oasis Inc. (US), Sucrest GmbH (Germany), Ganeden (US), Big Train Inc. (US), Oregon Chai (US), and Pevesa Biotech SA (Spain).
On February 15, 2021, Kerry Group plc announced its intention to acquire Biosearch Life, a Spanish nutraceutical and functional food company based in Granada with over 150 employees. Biosearch Life is recognized for its premium breast-milk-derived probiotics (Hereditum), science-backed botanical extracts (Exxentia), and natural omega-3 oils (Eupoly-3). The acquisition was planned through a friendly public tender offer subject to approval by the Spanish National Securities Markets Commission, with Grupo Lactalis Iberia SA, holding 29.5% of Biosearch Life’s share capital, committing to tender its entire stake in support of the offer.
Market Ranking
The omega-3 market is driven by increasing consumer demand for products backed by strong scientific evidence, clinically proven health benefits, and stability in various formulations. With growing interest in cardiovascular, brain, eye, and immune health, omega-3 has become a cornerstone ingredient across dietary supplements, functional foods, pharmaceuticals, and personal care, keeping the market highly competitive. Continuous innovation in extraction technologies, clinical validation, and sustainable sourcing strategies, particularly algae-based omega-3, is shaping the market dynamics and ensuring long-term growth.
The global omega-3 market is dominated by leading companies such as BASF SE (Germany), Cargill, Incorporated (US), dsm-firmenich (Netherlands), ADM (US), Kerry Group plc (Ireland), Aker BioMarine (Norway), Croda International PLC (UK), Corbion (Netherlands), Pelagia AS (Norway), KD Pharma Group SA (Switzerland), GC Rieber (Norway), Cooke Aquaculture Inc. (Canada), and GOLDEN OMEGA (Chile). These key players leverage a mix of advanced purification processes, strong global supply chains, and broad product portfolios to cater to diverse end-user industries, including dietary supplements, functional foods and beverages, infant formula, pharmaceuticals, pet nutrition, and cosmetics. By focusing on sustainability, innovation, and clinical efficacy, these companies have secured a competitive advantage in the global omega-3 market. Their ability to diversify product applications, from concentrated fish oils and krill oils to algae-derived alternatives, positions them at the forefront of serving the rising demand for natural, science-backed, and versatile health ingredients.
Smaller companies and emerging startups are capitalizing on the growing demand for omega-3 by developing innovative formulations, sustainable sourcing methods, and novel delivery formats such as gummies, emulsions, and fortified beverages. While their current market share remains relatively limited compared to established players, these companies bring agility, creativity, and disruptive technologies that add to the overall dynamism of the omega-3 sector. Collaborations with research institutions and partnerships with larger industry players are further supporting their expansion. With rising investment flows, increased clinical validation, and focused marketing strategies aimed at consumer awareness, these companies are well-positioned to accelerate their growth and carve out a niche in the global omega-3 market.
Related Reports:
Omega-3 Market by Type (DHA, EPA, & ALA), Source (Marine & Plant), Application (Dietary Supplements, Functional Foods & Beverages, Pharmaceuticals, Infant Formulas, and Pet Food & Feed), Form, Manufacturing Technology, and Region - Global Forecast to 2030
Contact:
Mr. Rohan Salgarkar
MarketsandMarkets Inc.
1615 South Congress Ave.
Suite 103,
Delray Beach, FL 33445
USA : 1-888-600-6441
sales@marketsandmarkets.com
This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.
SEND ME A FREE SAMPLE